A comprehensive search of different databases was used to yield the most relevant results and incorporated the available epidemiologic evidence to explore the relationship between the CYP2A6*4 whole-gene deletion polymorphism and the risk of lung cancer. This evidence concerns the gene CYP2A6 and lung carcinoma.